The annual number of drug overdose deaths in the United States involving opioids has more than quadrupled since 1999, a new report from the Congressional Research Service notes.
“CDC estimates that in 2016, more than 63,000 people died from a drug overdose, and more than 42,000 of these deaths involved prescription or illicit opioids.” See The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action, June 5, 2018.
Other new and updated reports from the Congressional Research Service include the following.
Increase in Illicit Fentanyl Overdose Deaths, CRS Insight, June 6, 2018
Capital Markets, Securities Offerings, and Related Policy Issues, June 8, 2018
The Rise and Decline of the Alien Tort Statute, CRS Legal Sidebar, June 6, 2018
Intelligence Planning, Programming, Budgeting and Evaluation Process (IPPBE), CRS In Focus, May 30, 2018
Recent Trends in Active-Duty Military Deaths, CRS In Focus, June 1, 2018
Expedited Citizenship through Military Service, CRS In Focus, May 11, 2018
Egypt: Background and U.S. Relations, updated June 7, 2018
Department of State, Foreign Operations and Related Programs: FY2019 Budget and Appropriations, updated June 8, 2018
How to Develop and Write a Grant Proposal, updated June 7, 2018
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.